drugset / Trial / NCT01255904

A Trial Of Oral Chloral Hydrate Versus Intranasal Dexmedetomidine For Sedated Abr Exams

NCT01255904

Phase 4 Completed 90 enrolled Baylor College of Medicine
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy of oral chloral hydrate to intranasal dexmedetomidine for the successful completion of a sedated ABR exam (hearing exam).

Timeline

Start
2011-08
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloral Hydrate Small molecule 50 mg/kg Oral
Subject Dexmedetomidine Other / unclassified 3 ug/kg Intranasal

Indications

No indication recorded.